{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T03:45:05Z","timestamp":1772682305379,"version":"3.50.1"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,6,19]],"date-time":"2024-06-19T00:00:00Z","timestamp":1718755200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,6,19]],"date-time":"2024-06-19T00:00:00Z","timestamp":1718755200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100012131","name":"Department of Science and Technology of Liaoning Province","doi-asserted-by":"publisher","award":["No.2020JH 2\/10300150"],"award-info":[{"award-number":["No.2020JH 2\/10300150"]}],"id":[{"id":"10.13039\/501100012131","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Inform Decis Mak"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Because spontaneous remission is common in IMN, and there are adverse effects of immunosuppressive therapy, it is important to assess the risk of progressive loss of renal function before deciding whether and when to initiate immunosuppressive therapy. Therefore, this study aimed to establish a risk prediction model to predict patient prognosis and treatment response to help clinicians evaluate patient prognosis and decide on the best treatment regimen.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>From September 2019 to December 2020, a total of 232 newly diagnosed IMN patients from three hospitals in Liaoning Province were enrolled. Logistic regression analysis selected the risk factors affecting the prognosis, and a dynamic online nomogram prognostic model was constructed based on extreme gradient boost, random forest, logistic regression machine learning algorithms. Receiver operating characteristic and calibration curves and decision curve analysis were utilized to assess the performance and clinical utility of the developed model.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 130 patients were in the training cohort and 102 patients in the validation cohort. Logistic regression analysis identified four risk factors: course\u2009\u2265\u20096 months, UTP, D-dimer and sPLA2R-Ab. The random forest algorithm showed the best performance with the highest AUROC (0.869). The nomogram had excellent discrimination ability, calibration ability and clinical practicability in both the training cohort and the validation cohort.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The dynamic online nomogram model can effectively assess the prognosis and treatment response of IMN patients. This will help clinicians assess the patient\u2019s prognosis more accurately, communicate with the patient in advance, and jointly select the most appropriate treatment plan.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12911-024-02568-2","type":"journal-article","created":{"date-parts":[[2024,6,19]],"date-time":"2024-06-19T06:04:14Z","timestamp":1718777054000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["A dynamic online nomogram for predicting renal outcomes of idiopathic membranous nephropathy"],"prefix":"10.1186","volume":"24","author":[{"given":"Feng","family":"Wang","sequence":"first","affiliation":[]},{"given":"Jiayi","family":"Xu","sequence":"additional","affiliation":[]},{"given":"Fumei","family":"Wang","sequence":"additional","affiliation":[]},{"given":"Xu","family":"Yang","sequence":"additional","affiliation":[]},{"given":"Yang","family":"Xia","sequence":"additional","affiliation":[]},{"given":"Hongli","family":"Zhou","sequence":"additional","affiliation":[]},{"given":"Na","family":"Yi","sequence":"additional","affiliation":[]},{"given":"Congcong","family":"Jiao","sequence":"additional","affiliation":[]},{"given":"Xuesong","family":"Su","sequence":"additional","affiliation":[]},{"given":"Beiru","family":"Zhang","sequence":"additional","affiliation":[]},{"given":"Hua","family":"Zhou","sequence":"additional","affiliation":[]},{"given":"Yanqiu","family":"Wang","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2024,6,19]]},"reference":[{"issue":"1","key":"2568_CR1","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/s41572-021-00303-z","volume":"7","author":"P Ronco","year":"2021","unstructured":"Ronco P, Beck L, Debiec H, Fervenza FC, Hou FF, Jha V, Sethi S, Tong A, Vivarelli M, Wetzels J. Membranous nephropathy. Nat Rev Dis Primers. 2021;7(1):69. https:\/\/doi.org\/10.1038\/s41572-021-00303-z","journal-title":"Nat Rev Dis Primers"},{"issue":"1","key":"2568_CR2","doi-asserted-by":"publisher","first-page":"10994","DOI":"10.1038\/s41598-020-67910-w","volume":"10","author":"R Hu","year":"2020","unstructured":"Hu R, Quan S, Wang Y, Zhou Y, Zhang Y, Liu L, Zhou XJ, Xing G. Spectrum of biopsy proven renal diseases in Central China: a 10-year retrospective study based on 34,630 cases. Sci Rep. 2020;10(1):10994. https:\/\/doi.org\/10.1038\/s41598-020-67910-w","journal-title":"Sci Rep"},{"issue":"1","key":"2568_CR3","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/S0272-6386(00)70316-7","volume":"35","author":"P Maisonneuve","year":"2000","unstructured":"Maisonneuve P, Agodoa L, Gellert R, Stewart JH, Buccianti G, Lowenfels AB, Wolfe RA, Jones E, Disney AP, Briggs D, et al. Distribution of primary renal diseases leading to end-stage renal failure in the United States, Europe, and Australia\/New Zealand: results from an international comparative study. Am J Kidney Dis. 2000;35(1):157\u201365. https:\/\/doi.org\/10.1016\/S0272-6386(00)70316-7","journal-title":"Am J Kidney Dis"},{"issue":"9","key":"2568_CR4","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.2215\/CJN.01330209","volume":"4","author":"MA Hladunewich","year":"2009","unstructured":"Hladunewich MA, Troyanov S, Calafati J, Cattran DC. The natural history of the non-nephrotic membranous nephropathy patient. Clin J Am Soc Nephrol. 2009;4(9):1417\u201322. https:\/\/doi.org\/10.2215\/CJN.01330209","journal-title":"Clin J Am Soc Nephrol"},{"issue":"3","key":"2568_CR5","doi-asserted-by":"publisher","first-page":"609","DOI":"10.2215\/CJN.04160413","volume":"9","author":"C Ponticelli","year":"2014","unstructured":"Ponticelli C, Glassock RJ. Glomerular diseases: membranous nephropathy\u2013a modern view. Clin J Am Soc Nephrol. 2014;9(3):609\u201316. https:\/\/doi.org\/10.2215\/CJN.04160413","journal-title":"Clin J Am Soc Nephrol"},{"issue":"1","key":"2568_CR6","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1093\/ckj\/sfy079","volume":"12","author":"M Diaz","year":"2019","unstructured":"Diaz M, Agraz I, Soler, MJ. Anti-phospholipase A2 receptor antibody and spontaneous remission in membranous nephropathy. Clin Kidney J. 2019;12(1):33\u20135. https:\/\/doi.org\/10.1093\/ckj\/sfy079","journal-title":"Clin Kidney J"},{"issue":"4","key":"2568_CR7","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1681\/ASN.2009080861","volume":"21","author":"N Polanco","year":"2010","unstructured":"Polanco N, Guti\u00e9rrez E, Covars\u00ed A, Ariza F, Carre\u00f1o A, Vigil A, Baltar J, Fern\u00e1ndez-Fresnedo G, Mart\u00edn C, Pons S, et al. Spontaneous remission of nephrotic syndrome in idiopathic membranous nephropathy. J Am Soc Nephrol. 2010;21(4):697\u2013704. https:\/\/doi.org\/10.1681\/ASN.2009080861","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"2568_CR8","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1159\/000529415","volume":"48","author":"J Zhang","year":"2023","unstructured":"Zhang J, Fan Z, Wang P, Zhang AH. Phospholipase A2 receptor antibodies and clinical prognosis in patients with idiopathic membranous nephropathy: an updated systematic review and meta-analysis. Kidney Blood Press Res. 2023;48(1):102\u201313. https:\/\/doi.org\/10.1159\/000529415","journal-title":"Kidney Blood Press Res"},{"key":"2568_CR9","doi-asserted-by":"publisher","first-page":"896654","DOI":"10.3389\/fimmu.2022.896654","volume":"13","author":"J Liu","year":"2022","unstructured":"Liu J, Zha Y, Zhang P, He P, He L. The association between serum complement 4 and kidney disease progression in idiopathic membranous nephropathy: a multicenter retrospective cohort study. Front Immunol. 2022;13:896654. https:\/\/doi.org\/10.3389\/fimmu.2022.896654","journal-title":"Front Immunol"},{"issue":"5","key":"2568_CR10","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1007\/s10157-020-02011-6","volume":"25","author":"HH Yeter","year":"2021","unstructured":"Yeter HH, Isik Gonul I, Eraslan E, Karacalik C, Ogut B, Guz G. Effects of phospholipase A(2) receptor and thrombospondin type-1 domain-containing 7A expression in glomerular basement membranes on treatment response and renal outcome in membranous nephropathy. Clin Exp Nephrol. 2021;25(5):488\u2013500. https:\/\/doi.org\/10.1007\/s10157-020-02011-6","journal-title":"Clin Exp Nephrol"},{"issue":"5","key":"2568_CR11","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1159\/000508665","volume":"45","author":"Y Zhang","year":"2020","unstructured":"Zhang Y, Liu Y, Liang L, Liu L, Tang X, Tang L, Chen P, Chen J, Wang Z, Cao W, et al. Effect of glomerular mannose-binding lectin deposition on the prognosis of idiopathic membranous nephropathy. Kidney Blood Press Res. 2020;45(5):713\u201326. https:\/\/doi.org\/10.1159\/000508665","journal-title":"Kidney Blood Press Res"},{"issue":"5","key":"2568_CR12","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1016\/j.kint.2018.06.005","volume":"94","author":"HY Wang","year":"2018","unstructured":"Wang HY, Cui Z, Xie LJ, Zhang LJ, Pei ZY, Chen FJ, Qu Z, Huang J, Zhang YM, Wang X, et al. HLA class II alleles differing by a single amino acid associate with clinical phenotype and outcome in patients with primary membranous nephropathy. Kidney Int. 2018;94(5):974\u201382. https:\/\/doi.org\/10.1016\/j.kint.2018.06.005","journal-title":"Kidney Int"},{"issue":"8","key":"2568_CR13","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.2215\/CJN.18021120","volume":"16","author":"WB Le","year":"2021","unstructured":"Le WB, Shi JS, Fan Y, Gong SW. HLA alleles and prognosis of PLA2R-related membranous nephropathy. Clin J Am Soc Nephrol. 2021;16(8):1221\u20137. https:\/\/doi.org\/10.2215\/CJN.18021120","journal-title":"Clin J Am Soc Nephrol"},{"issue":"4","key":"2568_CR14","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1016\/j.kint.2021.05.015","volume":"100","author":"BH Rovin","year":"2021","unstructured":"Rovin BH, Adler SG, Barratt J, Bridoux F, Burdge KA, Chan TM, Cook HT, Fervenza FC, Gibson KL, Glassock RJ, et al. Executive summary of the KDIGO 2021 guideline for the management of glomerular diseases. Kidney Int. 2021;100(4):753\u201379. https:\/\/doi.org\/10.1016\/j.kint.2021.05.015","journal-title":"Kidney Int"},{"issue":"4","key":"2568_CR15","doi-asserted-by":"publisher","first-page":"e173","DOI":"10.1016\/S1470-2045(14)71116-7","volume":"16","author":"VP Balachandran","year":"2015","unstructured":"Balachandran VP, Gonen M, Smith JJ, DeMatteo RP. Nomograms in oncology: more than meets the eye. Lancet Oncol. 2015;16(4):e173\u2013180. https:\/\/doi.org\/10.1016\/S1470-2045(14)71116-7","journal-title":"Lancet Oncol"},{"issue":"6","key":"2568_CR16","first-page":"901","volume":"36","author":"G Ohori Tatsuo","year":"2009","unstructured":"Ohori Tatsuo G, Riu Hamada M, Gondo T, Hamada R. Nomogram as predictive model in clinical practice. Gan Kagaku Ryoho. 2009;36(6):901\u20136. PMID: 19542708.","journal-title":"Gan Kagaku Ryoho"},{"issue":"2","key":"2568_CR17","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1007\/s11255-021-02859-x","volume":"54","author":"L Liu","year":"2022","unstructured":"Liu L, Wang H, Zhao B, Liu X, Sun Y, Mao Y. Nomogram to predict the progression of patients with primary membranous nephropathy and nephrotic syndrome. Int Urol Nephrol. 2022;54(2):331\u201341. https:\/\/doi.org\/10.1007\/s11255-021-02859-x","journal-title":"Int Urol Nephrol"},{"issue":"1","key":"2568_CR18","doi-asserted-by":"publisher","first-page":"2199092","DOI":"10.1080\/0886022X.2023.2199092","volume":"45","author":"M Li","year":"2023","unstructured":"Li M, Wang H, Lai X, Guo D, Jiang C, Fu Z, Liu X. A preliminary nomogram model for predicting relapse of patients with primary membranous nephropathy. Ren Fail. 2023;45(1):2199092. https:\/\/doi.org\/10.1080\/0886022X.2023.2199092","journal-title":"Ren Fail"},{"issue":"4","key":"2568_CR19","doi-asserted-by":"publisher","first-page":"3130","DOI":"10.3892\/etm.2020.9063","volume":"20","author":"J Zhang","year":"2020","unstructured":"Zhang J, Pan S, Li D, Li Z, Jin L, Zhou Z, Pan M. A nomogram for the prediction of renal outcomes among patients with idiopathic membranous nephropathy. Exp Ther Med. 2020;20(4):3130\u20137. https:\/\/doi.org\/10.3892\/etm.2020.9063","journal-title":"Exp Ther Med"},{"issue":"1","key":"2568_CR20","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1186\/s12882-022-02882-9","volume":"23","author":"T Chen","year":"2022","unstructured":"Chen T, Zhou Y, Zhu J, Chen X, Pan J. Prediction model of renal function recovery for primary membranous nephropathy with acute kidney injury. BMC Nephrol. 2022;23(1):247. https:\/\/doi.org\/10.1186\/s12882-022-02882-9","journal-title":"BMC Nephrol"},{"key":"2568_CR21","doi-asserted-by":"publisher","first-page":"317","DOI":"10.2147\/CIA.S349978","volume":"17","author":"Q Chen","year":"2022","unstructured":"Chen Q, Zhang Y, Zhang M, Li Z, Liu J. Application of machine learning algorithms to predict acute kidney injury in elderly orthopedic postoperative patients. Clin Interv Aging. 2022;17:317\u201330. https:\/\/doi.org\/10.2147\/CIA.S349978","journal-title":"Clin Interv Aging"},{"issue":"5","key":"2568_CR22","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1038\/s41416-021-01640-2","volume":"126","author":"S Chen","year":"2022","unstructured":"Chen S, Jiang L, Gao F, Zhang E, Wang T, Zhang N, Wang X, Zheng J. Machine learning-based pathomics signature could act as a novel prognostic marker for patients with clear cell renal cell carcinoma. Br J Cancer. 2022;126(5):771\u20137. https:\/\/doi.org\/10.1038\/s41416-021-01640-2","journal-title":"Br J Cancer"},{"issue":"Pt 1","key":"2568_CR23","first-page":"443","volume":"1","author":"J Churg","year":"1973","unstructured":"Churg J, Ehrenreich T. Membranous nephropathy. Perspect Nephrol Hypertens. 1973;1(Pt 1):443\u20138. PMID: 4536436.","journal-title":"Perspect Nephrol Hypertens"},{"issue":"12","key":"2568_CR24","doi-asserted-by":"publisher","first-page":"2930","DOI":"10.1681\/ASN.2015010091","volume":"26","author":"A Thompson","year":"2015","unstructured":"Thompson A, Cattran DC, Blank M, Nachman PH. Complete and partial remission as surrogate end points in membranous nephropathy. J Am Soc Nephrol. 2015;26(12):2930\u20137. https:\/\/doi.org\/10.1681\/ASN.2015010091","journal-title":"J Am Soc Nephrol"},{"issue":"6","key":"2568_CR25","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1007\/s10157-020-01864-1","volume":"24","author":"R Yamamoto","year":"2020","unstructured":"Yamamoto R, Imai E, Maruyama S, Yokoyama H, Sugiyama H, Nitta K, Tsukamoto T, Uchida S, Takeda A, Sato T, et al. Incidence of remission and relapse of proteinuria, end-stage kidney disease, mortality, and major outcomes in primary nephrotic syndrome: the Japan Nephrotic Syndrome Cohort Study (JNSCS). Clin Exp Nephrol. 2020;24(6):526\u201340. https:\/\/doi.org\/10.1007\/s10157-020-01864-1","journal-title":"Clin Exp Nephrol"},{"issue":"13","key":"2568_CR26","doi-asserted-by":"publisher","first-page":"2878","DOI":"10.1182\/blood-2008-06-165845","volume":"113","author":"SS Adam","year":"2009","unstructured":"Adam SS, Key NS, Greenberg CS. D-dimer antigen: current concepts and future prospects. Blood. 2009;113(13):2878\u201387. https:\/\/doi.org\/10.1182\/blood-2008-06-165845","journal-title":"Blood"},{"issue":"8","key":"2568_CR27","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1080\/10408363.2018.1529734","volume":"55","author":"J Favresse","year":"2018","unstructured":"Favresse J, Lippi G, Roy PM, Chatelain B, Jacqmin H, Ten Cate H, Mullier F. D-dimer: preanalytical, analytical, postanalytical variables, and clinical applications. Crit Rev Clin Lab Sci. 2018;55(8):548\u201377. https:\/\/doi.org\/10.1080\/10408363.2018.1529734","journal-title":"Crit Rev Clin Lab Sci"},{"issue":"1","key":"2568_CR28","doi-asserted-by":"publisher","first-page":"4836","DOI":"10.1038\/s41598-017-05210-6","volume":"7","author":"X Tan","year":"2017","unstructured":"Tan X, Chen G, Liu Y, Zhou L, He L, Liu D, Liu Y, Zhang F, Li H, Liu H. Serum D-dimer is a potential predictor for thromboembolism complications in patients with renal biopsy. Sci Rep. 2017;7(1):4836. https:\/\/doi.org\/10.1038\/s41598-017-05210-6","journal-title":"Sci Rep"},{"issue":"3","key":"2568_CR29","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/j.thromres.2012.04.015","volume":"130","author":"SJ Li","year":"2012","unstructured":"Li SJ, Guo JZ, Zuo K, Zhang J, Wu Y, Zhou CS, Lu GM, Liu ZH. Thromboembolic complications in membranous nephropathy patients with nephrotic syndrome-a prospective study. Thromb Res. 2012;130(3):501\u20135. https:\/\/doi.org\/10.1016\/j.thromres.2012.04.015","journal-title":"Thromb Res"},{"issue":"3","key":"2568_CR30","doi-asserted-by":"publisher","first-page":"513","DOI":"10.2215\/CJN.10131011","volume":"7","author":"BA Kerlin","year":"2012","unstructured":"Kerlin BA, Ayoob R, Smoyer WE. Epidemiology and pathophysiology of nephrotic syndrome-associated thromboembolic disease. Clin J Am Soc Nephrol. 2012;7(3):513\u201320. https:\/\/doi.org\/10.2215\/CJN.10131011","journal-title":"Clin J Am Soc Nephrol"},{"key":"2568_CR31","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1159\/000349976","volume":"181","author":"S Barbour","year":"2013","unstructured":"Barbour S, Reich H, Cattran D. Short-term complications of membranous nephropathy. Contrib Nephrol. 2013;181:143\u201351. https:\/\/doi.org\/10.1159\/000349976","journal-title":"Contrib Nephrol"},{"issue":"6","key":"2568_CR32","doi-asserted-by":"publisher","first-page":"102162","DOI":"10.1016\/j.rpth.2023.102162","volume":"7","author":"K Parker","year":"2023","unstructured":"Parker K, Ragy O, Hamilton P, Thachil J, Kanigicherla D. Thromboembolism in nephrotic syndrome: controversies and uncertainties. Res Pract Thromb Haemost. 2023;7(6):102162. https:\/\/doi.org\/10.1016\/j.rpth.2023.102162","journal-title":"Res Pract Thromb Haemost"},{"issue":"3\u20134","key":"2568_CR33","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1159\/000525913","volume":"147","author":"X Li","year":"2023","unstructured":"Li X, Xie X, Zhao Y, Wang G, Shao H, Zhang X. Some points for the KDIGO 2021 guideline for prophylactic anticoagulation in membranous nephropathy: is it clear enough for us to follow? Nephron. 2023;147(3\u20134):193\u20138. https:\/\/doi.org\/10.1159\/000525913","journal-title":"Nephron"},{"issue":"3","key":"2568_CR34","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1053\/j.semdp.2020.01.001","volume":"37","author":"Q Cai","year":"2020","unstructured":"Cai Q, Hendricks AR. Membranous nephropathy: a ten-year journey of discoveries. Semin Diagn Pathol. 2020;37(3):116\u201320. https:\/\/doi.org\/10.1053\/j.semdp.2020.01.001","journal-title":"Semin Diagn Pathol"},{"issue":"2","key":"2568_CR35","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1002\/cphy.c120028","volume":"3","author":"JD Imig","year":"2013","unstructured":"Imig JD, Ryan MJ. Immune and inflammatory role in renal disease. Compr Physiol. 2013;3(2):957\u201376. https:\/\/doi.org\/10.1002\/cphy.c120028","journal-title":"Compr Physiol"},{"issue":"2","key":"2568_CR36","doi-asserted-by":"publisher","first-page":"104","DOI":"10.2174\/1389450124666221026152647","volume":"24","author":"J Singh","year":"2023","unstructured":"Singh J, Jain A, Bhamra R, Rathi V, Dhingra AK. The mechanistic role of different mediators in the pathophysiology of nephropathy: a review. Curr Drug Targets. 2023;24(2):104\u201317. https:\/\/doi.org\/10.2174\/1389450124666221026152647","journal-title":"Curr Drug Targets"},{"issue":"2","key":"2568_CR37","doi-asserted-by":"publisher","first-page":"642","DOI":"10.26355\/eurrev_202301_31065","volume":"27","author":"DE Kazan","year":"2023","unstructured":"Kazan DE, Kazan S. Systemic immune inflammation index and pan-immune inflammation value as prognostic markers in patients with idiopathic low and moderate risk membranous nephropathy. Eur Rev Med Pharmacol Sci. 2023;27(2):642\u20138. https:\/\/doi.org\/10.26355\/eurrev_202301_31065","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"2568_CR38","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.2147\/JIR.S404591","volume":"16","author":"AH Zhang","year":"2023","unstructured":"Zhang AH, Dai GX, Zhang QD, Huang HD, Liu WH. The value of peripheral blood cell ratios in primary membranous nephropathy: a single center retrospective study. J Inflamm Res. 2023;16:1017\u201325. https:\/\/doi.org\/10.2147\/JIR.S404591","journal-title":"J Inflamm Res"},{"issue":"1","key":"2568_CR39","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1080\/0886022X.2019.1605294","volume":"41","author":"X Chen","year":"2019","unstructured":"Chen X, Chen Y, Ding X, Zhou Y, Lv Y, Li D, Chen B, Chen T, Chen C. Baseline proteinuria level is associated with prognosis in idiopathic membranous nephropathy. Ren Fail. 2019;41(1):363\u20139. https:\/\/doi.org\/10.1080\/0886022X.2019.1605294","journal-title":"Ren Fail"},{"issue":"1","key":"2568_CR40","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1080\/0886022X.2018.1487864","volume":"40","author":"M Yamaguchi","year":"2018","unstructured":"Yamaguchi M, Ando M, Katsuno T, Tsuboi N, Maruyama S. Urinary protein and renal prognosis in idiopathic membranous nephropathy: a multicenter retrospective cohort study in Japan. Ren Fail. 2018;40(1):435\u201341. https:\/\/doi.org\/10.1080\/0886022X.2018.1487864","journal-title":"Ren Fail"},{"issue":"1","key":"2568_CR41","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1080\/0886022X.2020.1792315","volume":"42","author":"P Yin","year":"2020","unstructured":"Yin P, Wang J, Liang W, Zhan L, Liu Y, Lin J, Chen X, He Y, Jian H, Xie Z, et al. Outcomes of primary membranous nephropathy based on serum anti-phospholipase A2 receptor antibodies and glomerular phospholipase A2 receptor antigen status: a retrospective cohort study. Ren Fail. 2020;42(1):675\u201383. https:\/\/doi.org\/10.1080\/0886022X.2020.1792315","journal-title":"Ren Fail"},{"key":"2568_CR42","doi-asserted-by":"publisher","first-page":"1521013","DOI":"10.1155\/2021\/1521013","volume":"2021","author":"X Liu","year":"2021","unstructured":"Liu X, Xue J, Guo X, Ding Y, Zhang Y, Zhang X, Huang Y, Huang B, Hu Z, Lu G, et al. A PLA2R-IgG4 antibody-based predictive model for assessing risk stratification of idiopathic membranous nephropathy. J Healthc Eng. 2021;2021:1521013. https:\/\/doi.org\/10.1155\/2021\/1521013","journal-title":"J Healthc Eng"},{"key":"2568_CR43","doi-asserted-by":"publisher","unstructured":"Kukuy OL, Cohen R, Gilburd B, Zeruya E, Weinstein T, Agur T, Dinour D, Beckerman P, Volkov A, Nissan J, et al. The prognostic value of anti-PLA2R antibodies levels in primary membranous nephropathy. Int J Mol Sci. 2023;24(10). https:\/\/doi.org\/10.3390\/ijms24109051","DOI":"10.3390\/ijms24109051"},{"issue":"24","key":"2568_CR44","doi-asserted-by":"publisher","first-page":"e7218","DOI":"10.1097\/MD.0000000000007218","volume":"96","author":"L Pang","year":"2017","unstructured":"Pang L, Zhang AM, Li HX, Du JL, Jiao LL, Duan N, Liu Y, Yu D. Serum anti-PLA2R antibody and glomerular PLA2R deposition in Chinese patients with membranous nephropathy: a cross-sectional study. Med (Baltim). 2017;96(24):e7218. https:\/\/doi.org\/10.1097\/MD.0000000000007218","journal-title":"Med (Baltim)"},{"issue":"9","key":"2568_CR45","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1016\/j.ekir.2020.06.040","volume":"5","author":"M Delafosse","year":"2020","unstructured":"Delafosse M, Ponlot E, Hanset N, Est\u00e8ve E, Boffa JJ, Dahan K. Serum albumin still of interest to predict outcomes in membranous nephropathy in the era of phospholipase A2 receptor. Kidney Int Rep. 2020;5(9):1611\u20132. https:\/\/doi.org\/10.1016\/j.ekir.2020.06.040","journal-title":"Kidney Int Rep"},{"issue":"1","key":"2568_CR46","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1186\/s12882-018-1011-5","volume":"19","author":"XD Zhang","year":"2018","unstructured":"Zhang XD, Cui Z, Zhang MF, Wang J, Zhang YM, Qu Z, Wang X, Huang J, Wang F, Meng LQ, et al. Clinical implications of pathological features of primary membranous nephropathy. BMC Nephrol. 2018;19(1):215. https:\/\/doi.org\/10.1186\/s12882-018-1011-5","journal-title":"BMC Nephrol"}],"container-title":["BMC Medical Informatics and Decision Making"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12911-024-02568-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12911-024-02568-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12911-024-02568-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,19]],"date-time":"2024-06-19T18:01:43Z","timestamp":1718820103000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedinformdecismak.biomedcentral.com\/articles\/10.1186\/s12911-024-02568-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,19]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["2568"],"URL":"https:\/\/doi.org\/10.1186\/s12911-024-02568-2","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-3258095\/v1","asserted-by":"object"}]},"ISSN":["1472-6947"],"issn-type":[{"value":"1472-6947","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,19]]},"assertion":[{"value":"12 August 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 June 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study has been approved by the Ethics Committee of Shengjing Hospital affiliated to China Medical University. All methods were carried out in accordance with declaration of Helsinki. The need for informed consent was waived by the Ethics Committee of Shengjing Hospital affiliated to China Medical University because it was a retrospective study(the ethics number: 2023PS847K).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"173"}}